Almac Expands Clinical Shipping Services
Almac, a contract development and manufacturing organization, has launched its “Direct to Patient” shipping service for clinical trials to European Union (EU) countries. The company introduced the service in the United States and Canada in October 2014.
The Direct to Patient offering guarantees all shipments are delivered direct to patients' homes on time to provide clinical trial sponsors a more cost-effective approach to conduct their studies. Patient compliance, efficiency and experience is also improved as they are offered a flexible and convenient method to participate in trials. The home delivery service further enhances Almac’s existing end-to-end clinical trial distribution service by co-ordinating all clinical trial (including temperature and non-temperature controlled) material shipments from clinical sites directly to patient's homes within the EU.